Avita Medical, Inc. Common Stock vs. ResMed Inc.
Avita Medical, Inc. Common Stock and ResMed Inc. are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| RCEL | RMD | |
|---|---|---|
| Market Cap | $240.30 million | $32.38 billion |
| Revenue (TTM) | — | $5.54 billion |
| Net Income (TTM) | — | $1.52 billion |
RMD leads on 1 of 1 size & scale factors.
Valuation
| RCEL | RMD | |
|---|---|---|
| P/E Ratio | — | 21.53 |
| Price / Book | — | 4.99 |
| Price / Sales | — | 5.85 |
RCEL and RMD split the valuation factors evenly.
Profitability
| RCEL | RMD | |
|---|---|---|
| Net Margin | — | 27.44% |
| Return on Equity | — | 23.41% |
RCEL and RMD split the profitability factors evenly.
Dividend
| RCEL | RMD | |
|---|---|---|
| Dividend Yield | — | 1.18% |
| Payout Ratio | — | 25.46 |
RCEL and RMD split the dividend factors evenly.
Risk & Sentiment
| RCEL | RMD | |
|---|---|---|
| Short Interest | 0.34% | 4.02% |
RCEL leads on 1 of 1 risk & sentiment factors.
Dig deeper: RCEL overview, RCEL financials, RMD overview, RMD financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.